1518 studies found for:    TNF
Show Display Options
Rank Status Study
1 Recruiting 99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity
Conditions: Psoriatic Arthritis;   Arthritis
Intervention: Other: 99mTc-anti-TNF-alpha Scintigraphy
2 Completed Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population
Condition: Ankylosing Spondylitis
Interventions: Drug: anti TNF alpha agent;   Drug: Anti TNF alpha therapy
3 Recruiting Intratumoral Administration of L19IL2/L19TNF
Condition: Malignant Melanoma, Skin
Intervention: Drug: L19IL2+L19TNF
4 Recruiting L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours
Conditions: Advanced Solid Tumors Amenable to Anthracycline Therapy;   Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
Intervention: Drug: Drug: L19TNFα in combination with doxorubicin
5 Recruiting Evaluation of a Standardized Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF Therapy
Condition: Spondylarthropathies
Interventions: Drug: Reduced doses of anti-TNF;   Drug: Stable doses of anti-TNF
6 Unknown  Lumbar Spinal Fibrosis and TNF Alpha Inhibition
Condition: Post Operative Sciatica by Lumbar Spinal Fibrosis
Interventions: Drug: TNF blocker;   Drug: Placebo
7 Not yet recruiting Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Anti-TNF suspended perioperatively;   Drug: Anti-TNFα continued perioperatively
8 Active, not recruiting Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: TNF-Kinoid
9 Recruiting To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis
Conditions: Psoriatic Arthritis;   Work Productivity
Intervention:
10 Unknown  TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis
Condition: Psoriasis
Intervention: Drug: subjects will receive either infliximab, adalimumab or etanercept
11 Recruiting Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors
Condition: Rheumatoid Arthritis
Intervention:
12 Completed Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study
Condition: Rheumatoid Arthritis
Interventions: Drug: progressive spacing of TNF-blocker injections;   Drug: DMARD maintenance
13 Active, not recruiting Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing
Intervention: Drug: TNF blockers (infliximab, adalimumab, etanercept)
14 Active, not recruiting Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
Condition: Juvenile Idiopathic Arthritis
Intervention: Other: Withdrawal of anti-TNF therapy
15 Recruiting Ultrasound and Anti-TNF Alpha Withdrawal in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: anti-TNF withdrawal (tanercept, adalimumab, infliximab, certolizumab, golimumab)
16 Active, not recruiting Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy
Condition: Rheumatoid Arthritis
Intervention: Other: SC anti-TNF
17 Unknown  Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
Condition: Drug Hypersensitivity
Intervention: Drug: anti-TNF a
18 Recruiting Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease;   Crohn's Disease;   Ulcerative Colitis
Intervention: Drug: Infliximab, adalimumab, certolizumab pegol
19 Completed A Study on Changes in IFN-gamma Levels Following Anti-TNF Treatment in Patients Undergoing Serial QuantiFERON-TB Gold In-Tube
Condition: Inflammatory Rheumatic Diseases
Intervention: Biological: QuantiFERON-TB Gold In-Tube (QFT-GIT)
20 Recruiting Anti TNF α Improves Endothelial Dysfunction in IBD Patients
Condition: Crohn's Disease
Interventions: Device: Endopath from Itamar medical - FDA approved device.;   Drug: Anti TNF Alfa.

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years